DOCSLIB.ORG

Mouse Pank1 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Pank1 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Pank1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Pank1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Pank1 gene (NCBI Reference Sequence: NM_001114339 ; Ensembl: ENSMUSG00000033610 ) is located on Mouse chromosome 19. 7 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 7 (Transcript: ENSMUST00000036584). Exon 3 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Pank1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP24-70P9 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Homozygous mutant has increased body weight, polyphagia, decreased serum triglyceride and glucose levels after fasting. Exon 3 starts from about 55.17% of the coding region. The knockout of Exon 3 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 13383 bp, and the size of intron 3 for 3'-loxP site insertion: 5230 bp. The size of effective cKO region: ~754 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 3 7 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Pank1 Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. It may be difficult to construct this targeting vector. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7254bp) | A(24.79% 1798) | C(22.24% 1613) | T(30.78% 2233) | G(22.19% 1610) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr19 - 34827624 34830623 3000 browser details YourSeq 81 1791 1927 3000 96.7% chr15 + 37471779 37730621 258843 browser details YourSeq 78 1791 1874 3000 95.0% chr12 - 10449688 10449769 82 browser details YourSeq 76 1791 1893 3000 95.3% chr14 - 35930780 35930884 105 browser details YourSeq 72 1819 1934 3000 83.2% chr16 + 8221634 8221733 100 browser details YourSeq 71 1808 1905 3000 83.4% chr1 - 168499323 168499400 78 browser details YourSeq 70 1791 1875 3000 88.0% chr3 - 49685235 49685317 83 browser details YourSeq 70 1791 1870 3000 92.4% chr13 - 83870526 83870604 79 browser details YourSeq 69 1791 1875 3000 95.0% chr12 - 98950223 98950319 97 browser details YourSeq 69 1791 1863 3000 98.7% chr1 + 143871582 143871828 247 browser details YourSeq 68 1791 1878 3000 94.9% chr17 - 47509677 47509908 232 browser details YourSeq 68 1796 1875 3000 92.5% chr11 - 79791750 79791829 80 browser details YourSeq 68 1791 1874 3000 94.8% chr1 - 155232258 155232349 92 browser details YourSeq 68 1786 1863 3000 94.9% chr15 + 86626584 86626667 84 browser details YourSeq 67 1809 1903 3000 96.0% chr14 - 21621579 21621675 97 browser details YourSeq 67 1791 1863 3000 97.2% chr10 + 116788885 116788986 102 browser details YourSeq 66 1791 1864 3000 97.2% chr1 - 176945658 176945783 126 browser details YourSeq 63 1819 1931 3000 94.4% chr16 + 39487209 39487337 129 browser details YourSeq 63 1809 1937 3000 94.4% chr10 + 94128914 94129052 139 browser details YourSeq 62 1798 1870 3000 95.8% chr11 + 114637076 114637184 109 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr19 - 34823870 34826869 3000 browser details YourSeq 49 1844 1912 3000 80.7% chr11 - 8114725 8114789 65 browser details YourSeq 45 1834 1890 3000 89.5% chr11 + 35969033 35969089 57 browser details YourSeq 44 1844 1898 3000 90.8% chr6 - 91812628 91812683 56 browser details YourSeq 44 1827 1890 3000 92.4% chr11 - 35558831 35558900 70 browser details YourSeq 44 1841 1894 3000 86.8% chr7 + 64345416 64345468 53 browser details YourSeq 44 1293 1369 3000 79.5% chr10 + 61469661 61469736 76 browser details YourSeq 43 1357 1889 3000 54.0% chr15 - 80814394 80814443 50 browser details YourSeq 42 2203 2276 3000 76.5% chr14 - 69773161 69773226 66 browser details YourSeq 42 1346 1404 3000 92.0% chr13 - 95212865 95212928 64 browser details YourSeq 42 1853 1910 3000 80.4% chr1 + 105254797 105254849 53 browser details YourSeq 39 2325 2400 3000 95.4% chr12 - 108021895 108022281 387 browser details YourSeq 39 1357 1887 3000 50.0% chr12 - 12837451 12837498 48 browser details YourSeq 39 1841 1891 3000 88.3% chr1 - 37700931 37700981 51 browser details YourSeq 39 1844 1890 3000 91.5% chr16 + 55842305 55842351 47 browser details YourSeq 39 2325 2368 3000 88.1% chr12 + 70449183 70449224 42 browser details YourSeq 39 1843 1891 3000 89.8% chr11 + 23165925 23165973 49 browser details YourSeq 39 1841 1889 3000 89.8% chr1 + 112451495 112451543 49 browser details YourSeq 38 1844 1891 3000 89.6% chr2 - 45986126 45986173 48 browser details YourSeq 38 1841 1890 3000 88.7% chr10 + 78404003 78404051 49 Note: The 3000 bp section downstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: Pank1 pantothenate kinase 1 [ Mus musculus (house mouse) ] Gene ID: 75735, updated on 10-Oct-2019 Gene summary Official Symbol Pank1 provided by MGI Official Full Name pantothenate kinase 1 provided by MGI Primary source MGI:MGI:1922985 See related Ensembl:ENSMUSG00000033610 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Pank; Pank1b Expression Ubiquitous expression in ovary adult (RPKM 4.1), liver adult (RPKM 3.2) and 28 other tissues See more Orthologs human all Genomic context Location: 19 C1; 19 See Pank1 in Genome Data Viewer Exon count: 8 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 19 NC_000085.6 (34806935..34883423, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 19 NC_000085.5 (34885384..34953945, complement) Chromosome 19 - NC_000085.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 4 transcripts Gene: Pank1 ENSMUSG00000033610 Description pantothenate kinase 1 [Source:MGI Symbol;Acc:MGI:1922985] Gene Synonyms 4632412I06Rik, 5430426F23Rik, Pank1, Pank1a, Pank1b Location Chromosome 19: 34,806,940-34,879,455 reverse strand. GRCm38:CM001012.2 About this gene This gene has 4 transcripts (splice variants), 210 orthologues, 3 paralogues, is a member of 1 Ensembl protein family and is associated with 14 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Pank1-201 ENSMUST00000036584.12 7414 548aa ENSMUSP00000043562.5 Protein coding CCDS50424 Q8K4K6 TSL:1 GENCODE basic Pank1-202 ENSMUST00000112460.2 2760 373aa ENSMUSP00000108079.1 Protein coding CCDS37966 Q543J7 Q8K4K6 TSL:1 GENCODE basic APPRIS P1 Pank1-204 ENSMUST00000238065.1 2342 251aa ENSMUSP00000157555.1 Protein coding - A0A494B9A0 GENCODE basic Pank1-203 ENSMUST00000237577.1 1138 No protein - Retained intron - - - 92.52 kb Forward strand 34.80Mb 34.82Mb 34.84Mb 34.86Mb 34.88Mb Genes Gm50116-201 >processed pseudogene (Comprehensive set... Contigs < AC125259.8 AC113244.19 > Genes (Comprehensive set... < Pank1-201protein coding < Pank1-202protein coding < Pank1-204protein coding < Mir107-201miRNA < Pank1-203retained intron Regulatory Build 34.80Mb 34.82Mb 34.84Mb 34.86Mb 34.88Mb Reverse strand 92.52 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding pseudogene processed transcript RNA gene Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000036584 < Pank1-201protein coding Reverse strand 72.52 kb ENSMUSP00000043... MobiDB lite Low complexity (Seg) Coiled-coils (Ncoils) TIGRFAM Type II pantothenate kinase Superfamily SSF53067 Pfam Type II pantothenate kinase PANTHER PTHR12280 PTHR12280:SF23 Gene3D 3.30.420.40 1.10.8.780 3.30.420.510 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant stop retained variant synonymous variant Scale bar 0 60 120 180 240 300 360 420 480 548 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Load more

Recommended publications
  • Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence After Radical Prostatectomy
    Int. J. Mol. Sci. 2015, 16, 3856-3869; doi:10.3390/ijms16023856 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy Chinyere Ibeawuchi 1, Hartmut Schmidt 2, Reinhard Voss 3, Ulf Titze 4, Mahmoud Abbas 5, Joerg Neumann 6, Elke Eltze 7, Agnes Marije Hoogland 8, Guido Jenster 9, Burkhard Brandt 10 and Axel Semjonow 1,* 1 Prostate Center, Department of Urology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Gebaeude 1A, Muenster D-48149, Germany; E-Mail: [email protected] 2 Center for Laboratory Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, Gebaeude 1A, Muenster D-48149, Germany; E-Mail: [email protected] 3 Interdisciplinary Center for Clinical Research, University of Muenster, Albert-Schweitzer-Campus 1, Gebaeude D3, Domagkstrasse 3, Muenster D-48149, Germany; E-Mail: [email protected] 4 Pathology, Lippe Hospital Detmold, Röntgenstrasse 18, Detmold D-32756, Germany; E-Mail: [email protected] 5 Institute of Pathology, Mathias-Spital-Rheine, Frankenburg Street 31, Rheine D-48431, Germany; E-Mail: [email protected] 6 Institute of Pathology, Klinikum Osnabrueck, Am Finkenhuegel 1, Osnabrueck D-49076, Germany; E-Mail: [email protected] 7 Institute of Pathology, Saarbrücken-Rastpfuhl, Rheinstrasse 2, Saarbrücken D-66113, Germany; E-Mail: [email protected] 8 Department
    [Show full text]
  • Transcriptomic Signature and Metabolic Programming of Bovine Classical and Nonclassical Monocytes Indicate Distinct Functional Specializations
    bioRxiv preprint doi: https://doi.org/10.1101/2020.10.30.362731; this version posted November 1, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Transcriptomic signature and metabolic programming of bovine classical and nonclassical monocytes indicate distinct functional specializations Stephanie C. Talker1,2, G. Tuba Barut1,2, Reto Rufener3, Lilly von Münchow4, Artur Summerfield1,2 1Institute of Virology and Immunology, Bern and Mittelhäusern, Switzerland 2Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland 3Institute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland 4 Bucher Biotec AG, Basel, Switzerland *Correspondence: Corresponding Author [email protected] Keywords: monocyte subsets, transcriptome, metabolism, cattle Abstract Similar to human monocytes, bovine monocytes can be split into CD14+CD16- classical and CD14-CD16+ nonclassical monocytes (cM and ncM, respectively). Here, we present an in-depth analysis of their steady-state transcriptomes, highlighting pronounced functional specializations. Gene transcription indicates that pro-inflammatory and antibacterial processes are associated with cM, while ncM appear to be specialized in regulatory/anti-inflammatory functions and tissue repair, as well as antiviral responses and T-cell immunomodulation. In support of these functional differences, we found that oxidative phosphorylation prevails in ncM, whereas cM are clearly biased towards aerobic glycolysis. Furthermore, bovine monocyte subsets differed in their responsiveness to TLR ligands, supporting an antiviral role of ncM. Taken together, these data clearly indicate a variety of subset-specific functions in cM and ncM that are likely to be transferable to monocyte subsets of other species, including humans.
    [Show full text]
  • Dissecting the Non-Canonical Functions of P53 Through Novel Target Identification and P53 Acetylation
    Dissecting the non-canonical functions of p53 through novel target identification and p53 acetylation Shang-Jui Wang Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Shang-Jui Wang All rights reserved ABSTRACT Dissecting the non-canonical functions of p53 through novel target identification and p53 acetylation Shang-Jui Wang It is well established that the p53 tumor suppressor plays a crucial role in controlling cell proliferation and apoptosis upon various types of stress. There is increasing evidence showing that p53 is also critically involved in various non-canonical pathways, including metabolism, autophagy, senescence and aging. Through a ChIP-on-chip screen, we identified a novel p53 metabolic target, pantothenate kinase-1 (PANK1). PanK1 catalyzes the rate-limiting step for CoA synthesis, and therefore, controls intracellular CoA content; Pank1 knockout mice exhibit defect in -oxidation and gluconeogenesis in the liver after starvation due to insufficient CoA levels. We demonstrated that PANK1 gene is a direct transcriptional target of p53. Although DNA damage-induced p53 upregulates PanK1 expression, depletion of PanK1 expression does not affect p53-dependent growth arrest or apoptosis. Interestingly, upon glucose starvation, PanK1 expression is significantly reduced in HCT116 p53 (-/-) but not in HCT116 p53 (+/+) cells, suggesting that p53 is required to maintain PanK1 expression under metabolic stress conditions. Moreover, by using p53-mutant mice, we observed that PanK activity and CoA levels are lower in livers of p53-null mice than that of wild-type mice upon starvation.
    [Show full text]
  • Downloaded Per Proteome Cohort Via the Web- Site Links of Table 1, Also Providing Information on the Deposited Spectral Datasets
    www.nature.com/scientificreports OPEN Assessment of a complete and classifed platelet proteome from genome‑wide transcripts of human platelets and megakaryocytes covering platelet functions Jingnan Huang1,2*, Frauke Swieringa1,2,9, Fiorella A. Solari2,9, Isabella Provenzale1, Luigi Grassi3, Ilaria De Simone1, Constance C. F. M. J. Baaten1,4, Rachel Cavill5, Albert Sickmann2,6,7,9, Mattia Frontini3,8,9 & Johan W. M. Heemskerk1,9* Novel platelet and megakaryocyte transcriptome analysis allows prediction of the full or theoretical proteome of a representative human platelet. Here, we integrated the established platelet proteomes from six cohorts of healthy subjects, encompassing 5.2 k proteins, with two novel genome‑wide transcriptomes (57.8 k mRNAs). For 14.8 k protein‑coding transcripts, we assigned the proteins to 21 UniProt‑based classes, based on their preferential intracellular localization and presumed function. This classifed transcriptome‑proteome profle of platelets revealed: (i) Absence of 37.2 k genome‑ wide transcripts. (ii) High quantitative similarity of platelet and megakaryocyte transcriptomes (R = 0.75) for 14.8 k protein‑coding genes, but not for 3.8 k RNA genes or 1.9 k pseudogenes (R = 0.43–0.54), suggesting redistribution of mRNAs upon platelet shedding from megakaryocytes. (iii) Copy numbers of 3.5 k proteins that were restricted in size by the corresponding transcript levels (iv) Near complete coverage of identifed proteins in the relevant transcriptome (log2fpkm > 0.20) except for plasma‑derived secretory proteins, pointing to adhesion and uptake of such proteins. (v) Underrepresentation in the identifed proteome of nuclear‑related, membrane and signaling proteins, as well proteins with low‑level transcripts.
    [Show full text]
  • A Variation in PANK2 Gene Is Causing Pantothenate Kinase
    www.nature.com/scientificreports OPEN A variation in PANK2 gene is causing Pantothenate kinase- associated Neurodegeneration in a Received: 9 January 2017 Accepted: 30 May 2017 family from Jammu and Kashmir – Published: xx xx xxxx India Arshia Angural1, Inderpal Singh2, Ankit Mahajan3, Pranav Pandoh4, Manoj K. Dhar3, Sanjana Kaul3, Vijeshwar Verma2, Ekta Rai1, Sushil Razdan5, Kamal Kishore Pandita6 & Swarkar Sharma 1 Pantothenate kinase-associated neurodegeneration is a rare hereditary neurodegenerative disorder associated with nucleotide variation(s) in mitochondrial human Pantothenate kinase 2 (hPanK2) protein encoding PANK2 gene, and is characterized by symptoms of extra-pyramidal dysfunction and accumulation of non-heme iron predominantly in the basal ganglia of the brain. In this study, we describe a familial case of PKAN from the State of Jammu and Kashmir (J&K), India based on the clinical findings and genetic screening of two affected siblings born to consanguineous normal parents. The patients present with early-onset, progressive extrapyramidal dysfunction, and brain Magnetic Resonance imaging (MRI) suggestive of symmetrical iron deposition in the globus pallidi. Screening the PANK2 gene in the patients as well as their unaffected family members revealed a functional single nucleotide variation, perfectly segregating in the patient’s family in an autosomal recessive mode of inheritance. We also provide the results of in-silico analyses, predicting the functional consequence of the identifiedPANK2 variant. Pantothenate Kinase-Associated Neurodegeneration (PKAN; OMIM# 234200) is a rare autosomal recessive, pro- gressive neurodegenerative movement disorder characterized by accumulation of non-heme iron in the brain, predominantly in the bilateral globus pallidus region of the basal ganglia1–3.
    [Show full text]
  • Supporting Information
    Supporting Information Friedman et al. 10.1073/pnas.0812446106 SI Results and Discussion intronic miR genes in these protein-coding genes. Because in General Phenotype of Dicer-PCKO Mice. Dicer-PCKO mice had many many cases the exact borders of the protein-coding genes are defects in additional to inner ear defects. Many of them died unknown, we searched for miR genes up to 10 kb from the around birth, and although they were born at a similar size to hosting-gene ends. Out of the 488 mouse miR genes included in their littermate heterozygote siblings, after a few weeks the miRBase release 12.0, 192 mouse miR genes were found as surviving mutants were smaller than their heterozygote siblings located inside (distance 0) or in the vicinity of the protein-coding (see Fig. 1A) and exhibited typical defects, which enabled their genes that are expressed in the P2 cochlear and vestibular SE identification even before genotyping, including typical alopecia (Table S2). Some coding genes include huge clusters of miRNAs (in particular on the nape of the neck), partially closed eyelids (e.g., Sfmbt2). Other genes listed in Table S2 as coding genes are [supporting information (SI) Fig. S1 A and C], eye defects, and actually predicted, as their transcript was detected in cells, but weakness of the rear legs that were twisted backwards (data not the predicted encoded protein has not been identified yet, and shown). However, while all of the mutant mice tested exhibited some of them may be noncoding RNAs. Only a single protein- similar deafness and stereocilia malformation in inner ear HCs, coding gene that is differentially expressed in the cochlear and other defects were variable in their severity.
    [Show full text]
  • PANK1 (NM 148978) Human Tagged ORF Clone – RG212009 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RG212009 PANK1 (NM_148978) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: PANK1 (NM_148978) Human Tagged ORF Clone Tag: TurboGFP Symbol: PANK1 Synonyms: PANK Vector: pCMV6-AC-GFP (PS100010) E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: Neomycin ORF Nucleotide >RG212009 representing NM_148978 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGAAGCTTATAAATGGCAAAAAGCAAACATTCCCATGGTTTGGCATGGACATCGGTGGAACGCTGGTTA AATTGGTGTATTTCGAGCCGAAGGATATTACAGCCGAAGAGGAGCAAGAGGAAGTGGAGAACCTGAAGAG CATCCGGAAGTATTTGACTTCTAATACTGCTTATGGGAAAACTGGGATCCGAGACGTCCACCTGGAACTG AAAAACCTGACCATGTGTGGACGCAAAGGGAACCTGCACTTCATCCGCTTTCCCAGCTGTGCTATGCACA GGTTCATTCAGATGGGCAGCGAGAAGAACTTCTCTAGCCTTCACACCACCCTCTGTGCCACAGGAGGCGG GGCTTTCAAATTCGAAGAGGACTTCAGAATGATTGCTGACCTGCAGCTGCATAAACTGGATGAACTGGAC TGTCTGATTCAGGGCCTGCTTTATGTCGACTCTGTTGGCTTCAACGGCAAGCCAGAATGTTACTATTTTG AAAATCCCACAAATCCTGAATTGTGTCAAAAAAAGCCGTACTGCCTTGATAACCCATACCCTATGTTGCT GGTTAACATGGGCTCAGGTGTCAGCATTCTAGCCGTGTACTCCAAGGACAACTATAAAAGAGTTACAGGG ACCAGTCTTGGAGGTGGAACATTCCTAGGCCTATGTTGCTTGCTGACTGGTTGTGAGACCTTTGAAGAAG CTCTGGAAATGGCAGCTAAAGGCGACAGCACCAATGTTGATAAACTGGTGAAGGACATTTACGGAGGAGA CTATGAACGATTTGGCCTTCAAGGATCTGCTGTAGCATCAAGCTTTGGCAACATGATGAGTAAAGAAAAG CGAGATTCCATCAGCAAGGAAGACCTCGCCCGGGCCACATTGGTCACCATCACCAACAACATTGGCTCCA
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • PANK1 Antibody (Center) Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap7159b
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 PANK1 Antibody (Center) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP7159b Specification PANK1 Antibody (Center) - Product Information Application WB, IHC-P,E Primary Accession Q8TE04 Other Accession Q8K4K6 Reactivity Human Predicted Mouse Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Antigen Region 332-360 PANK1 Antibody (Center) - Additional Information Gene ID 53354 Other Names Western blot analysis of anti-PANK1 Pab Pantothenate kinase 1, hPanK, hPanK1, (Cat. #AP7159b) in mouse kidney tissue Pantothenic acid kinase 1, PANK1, PANK lysate (35ug/lane). PANK1(arrow) was detected using the purified Pab. Target/Specificity This PANK1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 332-360 amino acids from the Central region of human PANK1. Dilution WB~~1:1000 IHC-P~~1:50~100 Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This Formalin-fixed and paraffin-embedded antibody is prepared by Saturated human cancer tissue reacted with the Ammonium Sulfate (SAS) precipitation primary antibody, which was followed by dialysis against PBS. peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data Storage demonstrates the use of this antibody for Maintain refrigerated at 2-8°C for up to 2 immunohistochemistry; clinical relevance has weeks. For long term storage store at -20°C not been evaluated. BC = breast carcinoma; in small aliquots to prevent freeze-thaw HC = hepatocarcinoma. cycles. Precautions PANK1 Antibody (Center) - Background PANK1 Antibody (Center) is for research use only and not for use in diagnostic or PANK1 belongs to the pantothenate kinase Page 1/2 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 therapeutic procedures.
    [Show full text]
  • Prevalence of Chromosomal Rearrangements Involving Non-ETS Genes in Prostate Cancer
    INTERNATIONAL JOURNAL OF ONCOLOGY 46: 1637-1642, 2015 Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer Martina KLUTH1*, RAMI GALAL1*, ANTJE KROHN1, JOACHIM WEISCHENFELDT4, CHRISTINA TSOURLAKIS1, LISA PAUSTIAN1, RAMIN Ahrary1, MALIK AHMED1, SEKANDER SCHERZAI1, ANNE MEYER1, HÜSEYIN SIRMA1, JAN KORBEL4, GUIDO SAUTER1, THORSTEN SCHLOMM2,3, RONALD SIMON1 and SARAH MINNER1 1Institute of Pathology, 2Martini-Clinic, Prostate Cancer Center, and 3Department of Urology, Section for Translational Prostate Cancer Research, University Medical Center Hamburg-Eppendorf; 4Genome Biology Unit, European Molecular Biology Laboratory (EMBL), D-69117 Heidelberg, Germany Received November 25, 2014; Accepted December 30, 2014 DOI: 10.3892/ijo.2015.2855 Abstract. Prostate cancer is characterized by structural rear- tumors that can be surgically treated in a curative manner, rangements, most frequently including translocations between ~20% of the tumors will progress to metastatic and hormone androgen-dependent genes and members of the ETS family refractory disease, accounting for >250.000 deaths per year of transcription factor like TMPRSS2:ERG. In a recent whole worldwide (1). Targeted therapies that would allow for an genome sequencing study we identified 140 gene fusions that effective treatment after failure of androgen withdrawal were unrelated to ETS genes in 11 prostate cancers. The aim therapy are lacking. of the present study was to estimate the prevalence of non-ETS Recent whole genome sequencing studies have shown that gene fusions. We randomly selected 27 of these rearrange- the genomic landscape of prostate cancer differs markedly ments and analyzed them by fluorescencein situ hybridization from that of other solid tumor types. Whereas, for example, (FISH) in a tissue microarray format containing 500 prostate breast or colon cancer is characterized by high-grade genetic cancers.
    [Show full text]
  • PANK1 (P-17): Sc-82284
    SAN TA C RUZ BI OTEC HNOL OG Y, INC . PANK1 (P-17): sc-82284 BACKGROUND PRODUCT The pantothenate kinase (PANK) family of proteins catalyzes the first step in Each vial contains 200 µg IgG in 1.0 ml of PBS with < 0.1% sodium azide coenzyme A (CoA). Pantothenate kinase 1 (PANK1) is a 598 amino acid mem - and 0.1% gelatin. ber of the pantothenate kinase family that plays a role in the physiological Blocking peptide available for competition studies, sc-82284 P, (100 µg regulation of the intracellular CoA concentration. Localized to the cytoplasm, pep tide in 0.5 ml PBS containing < 0.1% sodium azide and 0.2% BSA). PANK1 is strongly inhibited by acetyl-CoA and manyl-CoA, as well as by high concentration of non-esterified CoA (CoASH). Four known isoforms of PANK1 APPLICATIONS exist as a result of alternative splicing events. Of these isoforms, PANK1 α and PANK1 (P-17) is recommended for detection of PANK1 of human origin PANK1 β have been identified as the catalytically active isoforms. Isoform by Western Blotting (starting dilution 1:200, dilution range 1:100-1:1000), PANK1 α is most highly expressed in brain, heart, kidney, liver, skeletal muscle immunoprecipitation [1-2 µg per 100-500 µg of total protein (1 ml of cell and kidney. Isoform PANK1 β is detected at much lower levels in kidney, liver, brain and testis and is not detected in heart or skeletal muscle. lysate)], immunofluorescence (starting dilution 1:50, dilution range 1:50- 1:500) and solid phase ELISA (starting dilution 1:30, dilution range 1:30- REFERENCES 1:3000); non cross-reactive with isoforms PANK1-2, PANK1-3 or PANK1-4.
    [Show full text]
  • Transcriptional Profile of Human Anti-Inflamatory Macrophages Under Homeostatic, Activating and Pathological Conditions
    UNIVERSIDAD COMPLUTENSE DE MADRID FACULTAD DE CIENCIAS QUÍMICAS Departamento de Bioquímica y Biología Molecular I TESIS DOCTORAL Transcriptional profile of human anti-inflamatory macrophages under homeostatic, activating and pathological conditions Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas MEMORIA PARA OPTAR AL GRADO DE DOCTOR PRESENTADA POR Víctor Delgado Cuevas Directores María Marta Escribese Alonso Ángel Luís Corbí López Madrid, 2017 © Víctor Delgado Cuevas, 2016 Universidad Complutense de Madrid Facultad de Ciencias Químicas Dpto. de Bioquímica y Biología Molecular I TRANSCRIPTIONAL PROFILE OF HUMAN ANTI-INFLAMMATORY MACROPHAGES UNDER HOMEOSTATIC, ACTIVATING AND PATHOLOGICAL CONDITIONS Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas. Víctor Delgado Cuevas Tesis Doctoral Madrid 2016 Universidad Complutense de Madrid Facultad de Ciencias Químicas Dpto. de Bioquímica y Biología Molecular I TRANSCRIPTIONAL PROFILE OF HUMAN ANTI-INFLAMMATORY MACROPHAGES UNDER HOMEOSTATIC, ACTIVATING AND PATHOLOGICAL CONDITIONS Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas. Este trabajo ha sido realizado por Víctor Delgado Cuevas para optar al grado de Doctor en el Centro de Investigaciones Biológicas de Madrid (CSIC), bajo la dirección de la Dra. María Marta Escribese Alonso y el Dr. Ángel Luís Corbí López Fdo. Dra. María Marta Escribese
    [Show full text]